FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Power Metals entered into a cesium concentrate offtake agreement with Albemarle Corporation, a US$16 billion global critical ...
ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...
Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...
The global breast biopsy devices market is projected to experience a compound annual growth rate (CAGR) of approximately 6% ...
The global medical humidifier market is projected to experience a growth rate of approximately 6% over the next five years.
The Phase 3 STAR-221 study evaluating a domvanalimab-based combination in upper gastrointestinal cancers will be discontinued due to futilityArcus is continuing to expand its development program for ...
LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic shift. Zealthy is one of the fastest-growing telehealth weight-loss platforms in the ...
The "Peptide Cancer Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.The global peptide cancer vaccine market is expected ...
Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.The global expanded PTFE market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The ...
ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback